It is well known that neoangiogenesis is one of the most common mechanisms involved in the pathogenesis of cancer acting through the modulation of hypoxia-inducible factor (HIF) that, in turn, controls the synthesis of molecules such as vascular endothelial growth factor (VEGF), nitric oxide (NO), and angiopoetin-1. Here, VEGFA is linked to cancer.